New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
09:23 EDTAUXLAuxilium shares poised to advance, says RBC Capital
RBC Capital expects Auxilium's stock to rise closer to approval of the company's Peyronies treatment, which the firm believes is likely to occur in September. Increases in the volumes of the company's Testim treatment should also move the stock higher, added RBC ,which maintained an Outperform rating on the shares.
News For AUXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
06:13 EDTAUXLAuxilium reports Q3 EPS 27c, consensus 10c
Subscribe for More Information
October 21, 2014
08:13 EDTAUXLBioSpecifics announces FDA approval of sBLA for XIAFLEX
Subscribe for More Information
October 20, 2014
17:33 EDTAUXLAuxilium announces XIAFLEX approved for treatment of up to two DC joints
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use